Search - tctmd.com

Displaying 261 - 275 of 275

Sort: Relevancy | Date

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Infection After Primary PCI Rare but Serious

August 07, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

System Delays for STEMI Patients Linked to Subsequent Heart Failure Care

L.A. McKeown

September 23, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Thrombus Burden May Explain Disadvantage of Facilitated PCI

May 04, 2011

News Daily News

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

April 27, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Advertisement

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Infection After Primary PCI Rare but Serious

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Hope Renewed for Novel Anticoagulant Use in ACS

System Delays for STEMI Patients Linked to Subsequent Heart Failure Care

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ESC Congress 2011: Drugs, Devices Work Together

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Thrombus Burden May Explain Disadvantage of Facilitated PCI

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content